Brind.

Pfizer and BioNTech collaborate on COVID-19 vaccine development, alongside BNT327 joint development and AI stock benefits from tariffs.

1 report, 1 independent Updated Jul 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Pfizer Bristol-Myers Squibb BioNTech

How it developed

Newest first. Tap a step to see who reported it.

Jul 24Pfizer and BioNTech are targeting the oncology market for growth while continuing their COVID-19 vaccine development.Sub-event
Jul 9Pfizer/BioNTech collaborate on vaccine development; tariffs also benefit AI stocks.1 source
- Insider Monkey

Keep exploring

The entities involved

Pfizer
American multinational pharmaceutical and biotechnology corporation
- Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
BioNTech
Biotechnology company from Germany

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jul 9Insider MonkeyRecent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm BioNTech SE (NASDAQ:BNTX) is one of the 13 Best German Stocks to Invest in Now. It is a clinical-stage biotechnology company focused